BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23867050)

  • 1. An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
    Quinn B; Stoové M; Papanastasiou C; Dietze P
    Int J Drug Policy; 2013 Nov; 24(6):619-23. PubMed ID: 23867050
    [No Abstract]   [Full Text] [Related]  

  • 2. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users.
    Sheridan J; Butler R; Wheeler A
    J Psychoactive Drugs; 2009 Mar; 41(1):11-7. PubMed ID: 19455905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory study on association between family relationship and relapse among methamphetamine users in Compulsory Treatment System of Khon Kaen and Yasothon Provinces.
    Rodseeda P; Ratanasiri A; Kanato M; Pinitsoontorn S; Chiawiriyabunya I
    J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S1-5. PubMed ID: 21302405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of HIV risk among methamphetamine users in China.
    Kelly BC; Liu T; Zhang G; Hao W; Wang J
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):99-102. PubMed ID: 23421570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study of methamphetamine users' perspectives on barriers and facilitators of drug abstinence.
    Herbeck DM; Brecht ML; Christou D; Lovinger K
    J Psychoactive Drugs; 2014; 46(3):215-25. PubMed ID: 25052880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intimate partner violence and reproductive health among methamphetamine-using women in los angeles: a qualitative pilot study.
    Abdul-Khabir W; Hall T; Swanson AN; Shoptaw S
    J Psychoactive Drugs; 2014; 46(4):310-6. PubMed ID: 25188701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of methamphetamine use in Yunnan, China.
    Li J; Zhang R; Liu H
    AIDS Patient Care STDS; 2008 Jul; 22(7):543-4. PubMed ID: 18601581
    [No Abstract]   [Full Text] [Related]  

  • 9. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
    Shariatirad S; Maarefvand M; Ekhtiari H
    Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterpublic health and the design of drug services for methamphetamine consumers in Melbourne.
    Duff C; Moore D
    Health (London); 2015 Jan; 19(1):51-66. PubMed ID: 24948593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying Psychosocial Barriers to Drug Treatment Among Chinese Methamphetamine Users Using A 3-Step Latent Class Analysis.
    Wang J; Kelly BC; Liu T; Hao W
    J Subst Abuse Treat; 2016 Mar; 62():89-95. PubMed ID: 26738640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new survey of methamphetamine users in treatment: who they are, why they like "meth," and why they need additional services.
    Maxwell JC
    Subst Use Misuse; 2014 May; 49(6):639-44. PubMed ID: 24093526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine use among Australian workers and its implications for prevention.
    Roche AM; Pidd K; Bywood P; Freeman T
    Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
    Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China.
    Liao M; Kang D; Tao X; Li J; Qian Y; Wang G; Jiang B; Bi Z; Jia Y
    AIDS Care; 2013; 25(10):1236-44. PubMed ID: 23394142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Australian adolescent females in residential treatment who report using methamphetamines.
    Dixson G; Woolfenden S; Jayasinha R; Rawstorne P; Palmer K; Nathan S
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S384-S393. PubMed ID: 29266457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.